Literature DB >> 8852461

Anterior uveitis associated with rifabutin medication in AIDS patients.

K Becker1, M Schimkat, H Jablonowski, D Häussinger.   

Abstract

Eight episodes of rifabutin-associated anterior uveitis in AIDS patients are reported. Uveitis developed after two weeks to nine months of medication, commonly when rifabutin was administered along with clarithromycin and/or fluconazole. Recovery was closely correlated to suspending rifabutin early, while less dependent on total rifabutin dose or epidemiological patient characteristics. In two cases, discontinuation of rifabutin alone relieved ocular inflammation. Repeated exposure to rifabutin was successful with a reduced dosage in three patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8852461     DOI: 10.1007/bf01780648

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  7 in total

1.  Fluconazole and enhanced effect of rifabutin prophylaxis.

Authors:  P K Narang; C B Trapnell; J R Schoenfelder; J P Lavelle; J R Bianchine
Journal:  N Engl J Med       Date:  1994-05-05       Impact factor: 91.245

2.  Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network.

Authors:  S D Shafran; J Deschênes; M Miller; P Phillips; E Toma
Journal:  N Engl J Med       Date:  1994-02-10       Impact factor: 91.245

3.  Rifabutin prophylaxis and uveitis.

Authors:  J D Fuller; L E Stanfield; D E Craven
Journal:  N Engl J Med       Date:  1994-05-05       Impact factor: 91.245

4.  Uveitis associated with rifabutin prophylaxis.

Authors:  D Havlir; F Torriani; M Dubé
Journal:  Ann Intern Med       Date:  1994-10-01       Impact factor: 25.391

5.  Dose-limiting toxicity of rifabutin in AIDS-related complex: syndrome of arthralgia/arthritis.

Authors:  F P Siegal; D Eilbott; H Burger; K Gehan; B Davidson; A T Kaell; B Weiser
Journal:  AIDS       Date:  1990-05       Impact factor: 4.177

6.  The co-occurrence of Reiter's syndrome and acquired immunodeficiency.

Authors:  R Winchester; D H Bernstein; H D Fischer; R Enlow; G Solomon
Journal:  Ann Intern Med       Date:  1987-01       Impact factor: 25.391

7.  Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex for adults and adolescents infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1993-06-25
  7 in total
  2 in total

Review 1.  Drug-Drug interactions of clinical significance in the treatment of patients with Mycobacterium avium complex disease.

Authors:  J I Kuper; M D'Aprile
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

2.  Rifabutin-Cobicistat Drug Interaction Resulting in Severe Bilateral Panuveitis.

Authors:  Christopher B Toomey; Jeffrey Lee; Doran B Spencer
Journal:  Case Rep Ophthalmol       Date:  2020-04-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.